We are live on
!
Find out more
GF
Gray Foundation Portfolio holdings
AUM
$454M
1-Year Est. Return
38.19%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+38.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$351M
AUM Growth
+$13.6M
(+4%)
Cap. Flow
+$2.25M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
98.87%
Holding
16
New
4
Increased
3
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$4.66M |
| 2 |
iShares Expanded Tech Sector ETF
IGM
|
+$3.72M |
| 3 |
Analog Devices
ADI
|
+$1.77M |
| 4 |
Vanguard Health Care ETF
VHT
|
+$1.34M |
| 5 |
iShares MSCI All Country Asia ex Japan ETF
AAXJ
|
+$1.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ascendis Pharma A/S
ASND
|
+$7.72M |
| 2 |
iShares MSCI India ETF
INDA
|
+$3.78M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$272K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 54.09% |
| 2 | Communication Services | 6.08% |
| 3 | Real Estate | 3.11% |
| 4 | Technology | 0.48% |
| 5 | Industrials | 0.22% |
Similar funds
WCM
IIA
BWA
MI
GA
PIM
IP
ACM
Gray Foundation's Q4 2024 Portfolio in Review
As of Q4 2024, Gray Foundation held 16 positions worth $351M, up 4% from $337M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Gray Foundation's Q4 2024 filing shows 4 new, 3 increased, 1 reduced and 2 closed positions. Its largest new stake was Analog Devices: 8,000 shares worth $1.7M. The largest sale was Ascendis Pharma A/S, an estimated $7.72M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 54% of assets, up from 52% a quarter earlier, followed by Communication Services and Real Estate.
- Gray Foundation's largest Q4 2024 buy was Analog Devices: 8,000 shares worth $1.7M.
- Gray Foundation added most to iShares Biotechnology ETF in Q4 2024, an estimated $4.66M increase.
- Gray Foundation's biggest Q4 2024 reduction was iShares MSCI India ETF, cutting an estimated $3.78M.
- Gray Foundation fully exited Ascendis Pharma A/S in Q4 2024, selling an estimated $7.72M.
- Gray Foundation's ten largest holdings make up 99% of its $351M portfolio in Q4 2024.
- Gray Foundation opened 4 new positions and closed 2 in Q4 2024.
- Gray Foundation's portfolio value rose 4% quarter-over-quarter to $351M.
Based on Gray Foundation's 13F filing for Q4 2024, filed 4 Feb 2025.